Market Research Logo

Russia Pharmaceuticals and Healthcare Report Q2 2016

Russia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Russia's healthcare market is in a precarious position due to a severe lack of funding and anescalating burden of disease. The country's economic recession will see further pressure placed on thepopulation for provision of care. Amendments to Russia's pharmaceutical legislation will, however, favourdomestically-produced medicines over foreign drugmakers and multinational drugmakers will be pressuredto establish a domestic manufacturing presence to comply to related new regulations. Nonetheless, given itssheer market size and unmet potential, the country will remain attractive for investment by multinationalpharmaceutical firms for long-term growth.

Headline Expenditure Projections

Pharmaceuticals: RUB1.02trn (USD16.58bn) in 2015 to RUB1.15trn (USD15.42bn) in 2016; +12.7% inlocal currency terms and -7.0% in US dollar terms. Forecast unchanged from last quarter.

Healthcare: RUB5.29trn (USD86.31bn) in 2015 to RUB5.75trn (USD77.30bn) in 2016; +8.6% in localcurrency terms and -10.4% in US dollar terms. Forecast unchanged from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Russia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Russia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Russia Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Russia 2010-2015)
Table: Healthcare Personnel (Russia 2010-2015)
Table: Healthcare Activity (Russia 2010-2015)
Research & Development
Clinical Trials
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Retail Sector
Company Profile
Johnson & Johnson
Novartis
Pharmstandard
Veropharm
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Russia 1990-2025)
Table: Key Population Ratios (Russia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Russia 1990-2025)
Table: Population By Age Group (Russia 1990-2025)
Table: Population By Age Group % (Russia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report